POU5F1 and neoplasm: As expression of Oct4 is associated with tumor progression and chemotherapy resistance, we first examined the expression levels of Oct4 in 122 clinical specimens of superficial high-grade (stages T1-2) bladder TCC of 110 patients, among which 24 specimens were paired primary and recurrent samples from 12 patients.